ClinicalTrials.Veeva

Menu

LOAD VS Levofloxacine Concomitant

D

Damascus Hospital

Status and phase

Enrolling
Phase 4

Conditions

Helicobacter Pylori Infection

Treatments

Drug: Levofloxacin 500mg
Drug: Doxycycline

Study type

Interventional

Funder types

Other

Identifiers

NCT04626193
G-10-20

Details and patient eligibility

About

Comparison Efficacy of two weeks Therapy with Doxycycline,levofloxacine,Tinadizole Versus Levofloxacine,Tinadizole,Amocillin on Eradication of Helicobacter Pylori in Syrian population.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients are aged greater than 18 years old who have H. pylori infection diagnosed by any of following three methods:
  • Positive rapid urease test (CLOtest).
  • Histologic evidence of H. pylori by modified Giemsa staining.
  • Positive 13C-urea breath test. without prior eradication therapy and are willing to receive therapy.

Exclusion criteria

  • Children and teenagers aged less than 18 years.
  • Previous eradication treatment for H. pylori.
  • Patients who took any drug, which could influence the study results such as proton pump inhibitor, H2 blocker, mucosal protective agent and antibiotics.
  • History of gastrectomy.
  • Gastric malignancy, including adenocarcinoma and lymphoma,
  • Previous allergic reaction to antibiotics (Amoxicillin, Tinadizole,
  • Doxycycline,Bismuth subsalicylate,) and prompt pump inhibitors (Es- omeprazole).
  • Contraindication to treatment drugs.
  • Pregnant or lactating women.
  • Severe concurrent disease.
  • Liver cirrhosis.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Doxycyclien
Experimental group
Description:
Measure eradication rate of Helicobacter pylori infection with Doxycycline,Levofloxacien,tinadizole
Treatment:
Drug: Doxycycline
Levofloxacine
Active Comparator group
Description:
Measure eradication rate of Helicobacter pylori infection with Livofloxacine and tinadizole,amoxicilline
Treatment:
Drug: Levofloxacin 500mg

Trial contacts and locations

1

Loading...

Central trial contact

Marouf MH Alhalabi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems